Greg Fulcher
Royal North Shore Hospital(AU)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Pancreatic function and diabetes, Diabetes Management and Education, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes(2017)7,624 cited
- → Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials(2018)634 cited
- → Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome(2008)551 cited
- → Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events(2017)500 cited
- → Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus(2018)477 cited
- → Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial(2013)333 cited
- → Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function(2018)248 cited
- → Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes(2014)236 cited
- → The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism(2001)168 cited
- → Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal ( CANVAS‐R ): A randomized, placebo‐controlled trial(2017)165 cited